Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Early balding linked to higher heart disease risk.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

High androgen levels often cause female hirsutism and infertility.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

More hair loss leads to higher risk of psychosexual disorders, especially in women.

Injections with 0.5% minoxidil effectively treat female hair loss, increasing hair density and thickness.

Combining minoxidil and fibroblast growth factor is more effective for treating male hair loss than using either alone.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Men with androgenetic alopecia have different scalp oils and microbes compared to those without.

PCOS has three subtypes, with 11-oxygenated androgens increasing metabolic risk.

People with androgenetic alopecia have a higher risk of metabolic syndrome.

Finger length ratios don't predict baldness in men.

Red and infrared light therapy improves hair growth in balding patients.

DNA-flowcytometry is a reliable method to evaluate hair growth in androgenetic alopecia.

Androgenetic alopecia negatively affects self-esteem and daily stress, especially in young men.

Current treatments can slow hair loss and promote regrowth, with hair transplantation being most effective for advanced cases.

Current treatments can slow hair loss and promote regrowth, with hair transplantation being most effective for advanced cases.

Botulinum Toxin can improve hair growth in androgenetic alopecia, but more research is needed.

Both oral and topical minoxidil effectively regrow hair in men with similar results.

Androgens reduce THY1 in skin cells, leading to less fat, more fibrosis, and worse healing in males.

Age and androgen levels significantly affect meibomian gland structure and function.

ECM changes may play a role in hair loss, with differences between males and females.

Higher homocysteine levels may inhibit hair growth and are linked to androgenetic alopecia.

Using a laser helmet with Minoxidil works better for male hair loss than Minoxidil alone, with no extra side effects.